The Only Cancer Institute in the World Designed by a Patient

Jon Huntsman, Sr., has had cancer four times. So he’s spent enough time in cancer hospitals to know what he’d do differently when he designed one from scratch. That’s why Huntsman Cancer Institute is unlike any other. It looks different. Feels different.

Mindfulness Group Helps Manage Pain, Other Symptomsor Many Blood-Related Cancers

Mindfulness is a way to learn stress reduction and relaxation techniques, restore peace and well-being. For patients at Huntsman Cancer Institute (HCI), a weekly mindfulness group has helped reduce pain and other symptoms at.

The group started as a way to help people learn tools for reducing stress and cope with pain associated with cancer. Dr. Paul Thielking, a psychiatrist at HCI who leads the group, says meditation-based practices have a long history and are becoming a more prevalent form of chronic pain management in treatment centers across the country.

Learn more about HCI’s Mindfulness Group.

Precision prevention with genetic counseling

Long before Angelina Jolie told the world that she had tested positive for a mutation in the BRCA1 gene and why she decided to remove her breasts and ovaries, Huntsman Cancer Institute was using genetic testing to identify people at increased risk for cancer.

Genetic testing may be recommended by a genetic counselor, a health care professional with special training in inherited diseases. They look at a person’s health history and determine if testing will be helpful to find an inherited risk. They also interpret test results and help people take action to prevent cancer or detect it as early as possible.

Learn more about genetic testing at HCI and if genetic testing is right for you?

Plan Ahead with Advance Care Directives

No one plans on having a medical emergency, but if one happens, an advance directive outlines your plans and wishes for medical care. It tells your doctor and your family what decisions to make on your behalf, if you are unable to speak for yourself.

Even if you’re young and healthy, you can prepare for possible events with an advance directive. The forms for an advance directive vary by state, but most follow the same basic format.

Learn more about advance directives and how to fill yours out today.

It Takes Teamwork to Treat Cancer

Teamwork is the focus of HCI’s tumor boards, monthly meetings where all the specialists involved in treating a given type of cancer share their expertise to come up with a treatment plan for a patient. This exchange means every patient receives the best care, aiming not only for survival but the highest quality of life possible.

Together a team of doctors, social workers, investigative researchers, and other allied health professionals create a plan to treat an individual’s cancer with a combination of therapies. Learn how one patient, Dan Hedlund, is now cancer-free after undergoing treatment through HCI’s sarcoma multidisciplinary team.

Read more about how HCI gives patients access to cutting-edge therapies.

Recent News

Huntsman Cancer Institute CEO to Join Federal Moonshot Blue Ribbon Panel

Huntsman Cancer Institute’s CEO and director, Mary Beckerle, PhD, has been asked to join Vice President Joe Biden’s Moonshot Program Initiative as an invited member of a new Blue Ribbon Panel, tasked with advising the National Cancer Advisory Board (NCAB) on the scientific opportunities available to accelerate progress against cancer and evaluate potential new investments in cancer research.

Read More

Pulitzer Prize Winning Author Dr. Sid Mukherjee Joins HCI Panel Discussion

There are limits to precision medicine – the genome-mapping wave permeating health care these days. And no one is more aware of the gap between technology and science than cancer doctors. A panel gathered at Huntsman Cancer Institute (HCI) March 23 warned about the boundaries, even the dangers, of relying too much on “big data” to treat patients with uniquely variable diseases.

Read More

New Treatment Reduces Precancerous Polyps in Hereditary Cancer Patients

Inheriting a mutation in the APC gene leads to a nearly 100% lifetime risk of colorectal cancer. While colon cancer can be kept at bay by removing the large intestine, these patients also have up to a 15% risk of getting cancer in the small intestine, which is the leading cause of cancer death in this patient group. A new study published in the Journal of the American Medical Association (JAMA), has identified the first prevention treatment for these patients, a two-drug combination that significantly reduces the number and size of precancerous polyps in the small intestine.

Read More